Clinical trial
Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
NCT00404001 · Ironwood Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00404001 |
|---|---|
| Title | Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia |
| Official title | A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Safety and Efficacy of Orally Administered MD-0727 in Patients With Primary Hypercholesterolemia |
| Lead sponsor | Ironwood Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | MD-0727 |
| Enrollment | 150 |
| Start date | Nov 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Nov 27, 2006 |
| Last update posted | Oct 1, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: